top of page

Choose Your Child's Gender Through Advanced IVF Genetic Screening

In many countries, genetic screening before embryo transfer is standard practice in IVF procedures. However, regulations regarding gender selection vary. For example, in the UK, clinics perform Preimplantation Genetic Screening (PGS) to assess embryo viability and genetic health, but they do not disclose the gender of the embryos to intended parents. Additionally, the UK has strict regulations on the import and export of embryos.

In contrast, in the US, gender selection is legally permissible in IVF procedures. Intended parents have the option to choose the gender of their embryos, and clinics offer this service as part of the IVF process.

未命名 (1500 x 1080 像素) (1080 x 1080 像素) (10).png

Embryo Creation



PGS, or Preimplantation Genetic Screening, is a process designed to evaluate whether embryos possess the correct amount of genetic material. This genetic material, also known as DNA, is organized into structures called chromosomes. Just like an instruction manual, chromosomes provide essential information for proper development and functioning. However, if there are missing or extra chromosomes, it can disrupt this process, potentially leading to health complications. PGS helps identify these abnormalities, increasing the likelihood of successful pregnancies and reducing the risk of genetic disorders.

Gender Selection

Gender selection can aid in preventing the inheritance of specific genetic diseases, such as Cystic Fibrosis, Tay Sachs, Huntington’s disease, or sickle cell disease, which are carried on the X or Y chromosome. However, it's important to note that Microsort does not currently offer this service.

Preimplantation Genetic Diagnosis (PGD)​

Preimplantation Genetic Diagnosis (PGD) is a vital procedure for individuals concerned about passing on genetic diseases to their children. During in vitro fertilization (IVF), PGD enables physicians and embryologists to screen embryos for specific genetic conditions or abnormalities, ensuring the selection of healthy embryos for implantation

Through PGD testing, our experienced team of physicians and embryologists can meticulously analyze embryos' genetic composition, identifying potential abnormalities and empowering couples with crucial information for informed decision-making. PGD testing covers a spectrum of genetic disorders, including but not limited to

  • Down Syndrome (Trisomy 21)

  • Tay Sachs Disease

  • Hemophilia A and B

  • Sickle Cell Anemia

  • Gaucher’s Disease

PGD performed on a woman’s embryos for the most common chromosomal problems enables the physician and couple to determine which embryos will most likely result in a healthy, ongoing pregnancy. Additionally, for couples that have failed IVF cycles for unexplained reasons, preimplantation genetic diagnosis may provide important information in the determination of the cause(s) of the failures.

For further details or questions on our services, feel free to reach out to us. 


What is the Difference?

Both PGT-A and PGT-M involve performing a biopsy on the embryos, usually at the blastocyst stage. However, the genetic information obtained and the purpose of testing differ. PGT-A focuses on assessing the overall chromosomal health of embryos, while PGT-M targets specific disease-causing genes or mutations, aiming to identify embryos at risk of hereditary disorders.

What is PGT testing for?

Preimplantation Genetic Testing (PGT) is a cutting-edge technique in assisted reproductive medicine, examining embryos for genetic abnormalities before implantation. It identifies conditions like Down syndrome or cystic fibrosis, ensuring only healthy embryos are chosen for IVF. PGT detects potential abnormalities early, improving pregnancy success and minimizing inherited disorder risks. It enhances IVF success rates and eases emotional and financial strains. PGT signifies a significant advancement, providing hope to couples in fertility treatment.

The PGT Process:

bottom of page